Cannabiz Australia reports
Australian biotechnology company CannaPacific and the University of Newcastle have announced a collaboration to advance the development of new cannabinoid-based pain treatments.
CannaPacific’s pharmaceutical development team are producing high-purity actives, isolated from in-house developed cannabis strains, which will be screened at the University of Newcastle using pain signalling assays.
It is hoped the insights gained will enable the development of improved pain medicines.
CannaPacific chief scientific officer Tim Bowser said: “Attaining insights into the ancient human endocannabinoid system is leading researchers to believe that medicinal cannabis has an untapped role to play in both pain signalling and perception.
Read full report. https://www.cannabiz.com.au/cannapacific-and-the-university-of-newcastle-join-forces-to-research-cannabinoid-pain-treatment-options/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%20231220&utm_content=Cannabiz%20newsletter%20231220+CID_0d3b3c3414a462afd3a05053c9468a36&utm_source=CampaignMonitor&utm_term=READ%20MORE